相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MiR-539-5p inhibits the inflammatory injury in septic H9c2 cells by regulating IRAK3
Xiaochen Hu et al.
MOLECULAR BIOLOGY REPORTS (2022)
Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway
Jing Sun et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages
Ioanna Pantazi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Neuroprotective effects of lignan 7-hydroxymatairesinol (HMR/lignan) in a rodent model of Parkinson's disease
Claudio Giuliano et al.
NUTRITION (2020)
Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses
Yao Zhang et al.
MOLECULAR THERAPY (2020)
IRAK family in inflammatory autoimmune diseases
Lin-Chong Su et al.
AUTOIMMUNITY REVIEWS (2020)
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Sofie Voet et al.
EMBO MOLECULAR MEDICINE (2019)
Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE)
Baozhu Liu et al.
JOURNAL OF AUTOIMMUNITY (2019)
Non-cell autonomous modulation of tyrosine hydroxylase by HMGB1 released from astrocytes in an acute MPTP-induced Parkinsonian mouse model
Soo Jeong Kim et al.
LABORATORY INVESTIGATION (2019)
Neuroprotective effects of acetyl-L-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects
Susan Burks et al.
NEUROSCIENCE LETTERS (2019)
Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease
Xue Jiang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson's Disease
Holly F. Green et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease
Pedro A. Dionisio et al.
CELL DEATH & DISEASE (2019)
Cholesterol Metabolism in the Brain and Its Association with Parkinson's Disease
Uram Jin et al.
EXPERIMENTAL NEUROBIOLOGY (2019)
Biochanin A protects against angiotensin II-induced damage of dopaminergic neurons in rats associated with the increased endophilin A2 expression
Hai-Xia Xue et al.
BEHAVIOURAL PHARMACOLOGY (2019)
Human Clinical-Grade Parthenogenetic ESC-Derived Dopaminergic Neurons Recover Locomotive Defects of Nonhuman Primate Models of Parkinson's Disease
Yu-Kai Wang et al.
STEM CELL REPORTS (2018)
NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease
Li Cheng et al.
JOURNAL OF NEUROINFLAMMATION (2018)
IRAK-M Deficiency Exacerbates Ischemic Neurovascular Injuries in Experimental Stroke Mice
Chenfei Lyu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines
Qamre Alam et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Preconditioning with recombinant high-mobility group box 1 induces ischemic tolerance in a rat model of focal cerebral ischemia-reperfusion
Chen Wang et al.
JOURNAL OF NEUROCHEMISTRY (2016)
In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
Matteo Santoro et al.
NEUROBIOLOGY OF DISEASE (2016)
Role of sulfiredoxin as a peroxiredoxin-2 denitrosylase in human iPSC-derived dopaminergic neurons
Carmen R. Sunico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Interleukin-1 receptor associated kinase inhibitors: Potential therapeutic agents for inflammatory- and immune-related disorders
Malkeet Singh Bahia et al.
CELLULAR SIGNALLING (2015)
IRAK-M Promotes Alternative Macrophage Activation and Fibroproliferation in Bleomycin-Induced Lung Injury
Megan N. Ballinger et al.
JOURNAL OF IMMUNOLOGY (2015)
The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction
Amit Saxena et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases
Joshua A. Smith et al.
BRAIN RESEARCH BULLETIN (2012)
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury
Lauren Henl Martens et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation
Lorna Ringwood et al.
CYTOKINE (2008)
Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins
Tanya M. Watters et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
Regulations and roles of the interleukin-1 receptor associated kinases (IRAKs) in innate and adaptive immunity
Lu Gan et al.
IMMUNOLOGIC RESEARCH (2006)
MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration
TG Wang et al.
FASEB JOURNAL (2005)
Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-Binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the toll-like receptor signaling
S Sato et al.
JOURNAL OF IMMUNOLOGY (2003)
IRAK-M is a negative regulator of toll-like receptor signaling
K Kobayashi et al.
CELL (2002)
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
N Suzuki et al.
NATURE (2002)
分享论文
